CN111166289B - A remote endocrine disorder detection device - Google Patents
A remote endocrine disorder detection device Download PDFInfo
- Publication number
- CN111166289B CN111166289B CN202010007492.2A CN202010007492A CN111166289B CN 111166289 B CN111166289 B CN 111166289B CN 202010007492 A CN202010007492 A CN 202010007492A CN 111166289 B CN111166289 B CN 111166289B
- Authority
- CN
- China
- Prior art keywords
- terminal
- remote
- detector
- detection
- hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 51
- 208000017701 Endocrine disease Diseases 0.000 title claims abstract description 15
- 208000030172 endocrine system disease Diseases 0.000 title claims abstract description 8
- 210000004369 blood Anatomy 0.000 claims abstract description 67
- 239000008280 blood Substances 0.000 claims abstract description 67
- 238000012360 testing method Methods 0.000 claims abstract description 55
- 239000003163 gonadal steroid hormone Substances 0.000 claims abstract description 30
- 238000002965 ELISA Methods 0.000 claims abstract description 23
- 238000004891 communication Methods 0.000 claims abstract description 15
- 229940088597 hormone Drugs 0.000 claims description 29
- 239000005556 hormone Substances 0.000 claims description 29
- 238000004458 analytical method Methods 0.000 claims description 27
- 230000003993 interaction Effects 0.000 claims description 26
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 23
- 239000008103 glucose Substances 0.000 claims description 23
- 238000003908 quality control method Methods 0.000 claims description 15
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000009151 Luteinizing Hormone Human genes 0.000 claims description 4
- 108010073521 Luteinizing Hormone Proteins 0.000 claims description 4
- 102000003946 Prolactin Human genes 0.000 claims description 4
- 108010057464 Prolactin Proteins 0.000 claims description 4
- 229940040129 luteinizing hormone Drugs 0.000 claims description 4
- 229940097325 prolactin Drugs 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 3
- 230000007613 environmental effect Effects 0.000 claims description 3
- 229960005309 estradiol Drugs 0.000 claims description 3
- 229930182833 estradiol Natural products 0.000 claims description 3
- 238000005286 illumination Methods 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 239000000186 progesterone Substances 0.000 claims description 3
- 229960003387 progesterone Drugs 0.000 claims description 3
- 229960003604 testosterone Drugs 0.000 claims description 3
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims 2
- 229940028334 follicle stimulating hormone Drugs 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 5
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 239000003547 immunosorbent Substances 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4227—Evaluating particular parts, e.g. particular organs endocrine glands, i.e. thyroid, adrenals, hypothalamic, pituitary
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Electrochemistry (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明涉及一种远程内分泌紊乱检测设备。建立了远程的性激素六项的检测设备，且结合远程设备的所需的特点，使用酶联免疫法对性激素6项进行检测，降低设备的设置成本。在进行性激素检测时使用电化学血糖传感器检测血糖含量，同时使用该检测的血糖含量对性激素6项的检测结果进行定量的标定，避免了因为终端的使用环境造成酶联免疫法检测的精度降低；还设置了专门的远程沟通功能，针对各种需要都有相应的应对措施，多样的沟通方式可以很好的保证用户的隐私，且还可以方便没有移动终端的人群使用。
The invention relates to a remote endocrine disorder detection device. A remote test equipment for six sex hormones was established, and combined with the required characteristics of the remote equipment, the enzyme-linked immunoassay was used to detect six sex hormones to reduce the cost of equipment setup. In the detection of sex hormones, the electrochemical blood sugar sensor is used to detect the blood sugar content, and at the same time, the detected blood sugar content is used to quantitatively calibrate the test results of the six sex hormones, which avoids the decrease in the accuracy of the enzyme-linked immunoassay due to the use environment of the terminal; A special remote communication function is also set up, and there are corresponding countermeasures for various needs. The various communication methods can well guarantee the privacy of users, and can also be convenient for people who do not have mobile terminals.
Description
技术领域technical field
本发明涉及内分泌检测领域，尤其涉及远程内分泌紊乱检测设备。The invention relates to the field of endocrine detection, in particular to remote endocrine disorder detection equipment.
背景技术Background technique
内分泌紊乱，即内分泌失调。人体有内分泌系统，分泌各种激素和神经系统一起调节人体的代谢和生理功能。正常情况下各种激素是保持平衡的。如因某种原因使这种平衡打破了（某种激素过多或过少）这就造成内分泌紊乱，会引起相应的临床表现。男性和女性都可能出现内分泌紊乱。在内分泌紊乱中最容易出现的是女性的内分泌失调，导致心情烦躁、月经推迟等。Endocrine disorders, that is, endocrine disorders. The human body has an endocrine system, which secretes various hormones and regulates the metabolism and physiological functions of the human body together with the nervous system. Under normal circumstances, various hormones are kept in balance. If this balance is broken for some reason (too much or too little of a certain hormone), this will cause endocrine disorders and cause corresponding clinical manifestations. Endocrine disturbances can occur in both men and women. Endocrine disorders are most likely to occur in women, leading to irritability and delayed menstruation.
现有的针对女性内分泌失调的检测方式一般是去医院进行性激素水平的检测，但是去医院的时间成本和经理成本都比较高。而目前的远程医疗设备一般仅仅局限在可以检测用户的血糖等比较简单的指标上。针对性激素的检测如果采用高精度的检测设备，其成分太高，用户无法承担，而且由于内分泌失调的偶发性，用户也没有必要购买专门针对内分泌失调的设备。如果仅仅使用试纸检测内分泌，一方面用户没有分析的能力，另一方面血液检测时用户也不方便自行抽血。The existing detection method for female endocrine disorders is generally to go to the hospital to test the level of sex hormones, but the time cost and manager cost of going to the hospital are relatively high. However, the current telemedicine equipment is generally limited to relatively simple indicators such as the detection of the user's blood sugar. If high-precision detection equipment is used for the detection of targeted hormones, the composition is too high for users to afford, and because of the sporadic nature of endocrine disorders, users do not need to purchase equipment specifically for endocrine disorders. If you only use test strips to detect endocrine, on the one hand, users do not have the ability to analyze, and on the other hand, it is inconvenient for users to draw blood by themselves during blood testing.
发明内容Contents of the invention
针对上述内容，为解决上述问题提供一种远程内分泌紊乱检测设备，包括远程主机、远程分析模块、终端检测仪、终端交互模块、移动设备终端；远程主机连接远程分析模块、终端检测仪、终端交互模块、移动设备终端，终端检测仪连接终端交互模块、移动设备终端；远程分析模块连接终端交互模块、移动设备终端；In view of the above content, a remote endocrine disorder detection device is provided to solve the above problems, including a remote host, a remote analysis module, a terminal detector, a terminal interaction module, and a mobile device terminal; the remote host is connected to the remote analysis module, the terminal detector, and the terminal interaction Module, mobile device terminal, terminal detector connects terminal interaction module, mobile device terminal; remote analysis module connects terminal interaction module, mobile device terminal;
终端检测仪用于对性激素水平进行检测，其设置有主控制器、录音设备、显示设备、电化学血糖传感器、酶联免疫性激素检测仪；主控制器连接录音设备、显示设备、电化学血糖传感器、酶联免疫性激素检测仪；显示设备用于在检测时显示使用者需要回答的问题，录音设备用于记录使用者的语音；The terminal detector is used to detect the level of sex hormones. It is equipped with a main controller, a recording device, a display device, an electrochemical blood sugar sensor, and an enzyme-linked immune hormone detector; the main controller is connected to the recording device, a display device, and an electrochemical blood sugar sensor. , ELISA hormone detector; the display device is used to display the questions that the user needs to answer during the test, and the recording device is used to record the user's voice;
电化学血糖传感器用于检测血糖含量；酶联免疫性激素检测仪包括检测器和激素检测试纸；检测试纸包括7条检测线和1条质控线；检测器包括试纸插槽和8个与试纸上的检测线和质控线对应的检测头；The electrochemical blood sugar sensor is used to detect the blood sugar content; the ELISA hormone detection instrument includes a detector and a hormone detection test paper; the detection test paper includes 7 detection lines and 1 quality control line; the detector includes a test paper slot and 8 test papers The detection head corresponding to the detection line and quality control line;
终端检测仪将检测的性激素6项水平以及其记录的语音发送至远程主机；终端交互模块和移动设备终端用于供用户与医生进行语音视频交流；远程分析模块用于显示性激素6项水平以及播放记录的语音，并供医生与用于进行语音视频交流。The terminal detector sends the detected levels of the six sex hormones and the recorded voice to the remote host; the terminal interaction module and the mobile device terminal are used for voice and video communication between the user and the doctor; the remote analysis module is used to display the levels of the six sex hormones and play The recorded voice can be used by doctors for voice and video communication.
终端检测仪、终端交互模块一体设置，终端交互模块设置有终端显示屏、耳机、麦克风、高清摄像头；移动设备终端为手机或者平板电脑。The terminal detector and the terminal interaction module are integrated, and the terminal interaction module is equipped with a terminal display screen, earphones, microphones, and high-definition cameras; the mobile device terminal is a mobile phone or a tablet computer.
电化学血糖传感器内设置有电化学血糖监测模块和制样模块，用于对血液样品的血样进行电化学监测，并将血液样品制作成血清加载至激素检测试纸上；The electrochemical blood sugar sensor is equipped with an electrochemical blood sugar monitoring module and a sample preparation module, which are used to electrochemically monitor the blood sample of the blood sample, and make the blood sample into serum and load it on the hormone detection test paper;
激素检测试纸上设置有用于检测卵泡生成激素FSH、黄体生成激素LH、雌二醇 E2、孕酮P、睾酮T、催乳激素PRL共六项的酶联免疫检测线以及一条用于检测检测试纸是否正常的质控线和一条基于酶联免疫检测血糖含量的检测线；Hormone detection test paper is equipped with six enzyme-linked immunoassay lines for detection of follicle generating hormone FSH, luteinizing hormone LH, estradiol E2, progesterone P, testosterone T, and prolactin PRL, and one for detecting whether the test paper is Normal quality control line and a test line based on enzyme-linked immunosorbent assay for blood sugar content;
当激素检测试纸插入试纸插槽时，每一条检测线和质控线的上方均设置有一个发光头和一个受光头；发光头提供固定强度的照明，受光头用于检测检测线或者质控线对应波长的的光亮度；When the hormone detection test paper is inserted into the test paper slot, a light-emitting head and a light-receiving head are arranged above each test line and quality control line; the light-emitting head provides a fixed intensity of illumination, and the light-receiving head is used to detect the test line or quality control line The brightness of the corresponding wavelength;
终端检测仪将收集到的电化学血糖传感器检测的血糖浓度和8个受光头检测的光亮度发送给远程主机。The terminal detector sends the collected blood glucose concentration detected by the electrochemical blood glucose sensor and the light brightness detected by the 8 light heads to the remote host.
远程主机内存储有性激素6项和血糖对应的酶联免疫的工作曲线，远程主机根据电化学血糖传感器检测的血糖浓度对血糖对应的受光头检测到的光亮度进行标定，然后根据标定的血糖浓度对性激素6项的指标进行定量计算，从而消除因环境和设备误差造成的酶联免疫检测的误差。The remote host stores the 6 items of sex hormones and the ELISA working curve corresponding to the blood glucose. The remote host calibrates the brightness of the light detected by the light head corresponding to the blood glucose according to the blood glucose concentration detected by the electrochemical blood glucose sensor, and then according to the calibrated blood glucose concentration Quantitative calculation of 6 indicators of sex hormones is performed to eliminate errors in enzyme-linked immunoassays caused by environmental and equipment errors.
远程主机将性激素6项的指标以及终端检测仪检测时记录的语音发送至远程分析模块，远程分析模块收集医生在远程分析模块针对性激素6项指标的分析结果，并将分析结果发送给移动设备终端。The remote host sends the six indicators of sex hormones and the voice recorded by the terminal detector to the remote analysis module, and the remote analysis module collects the analysis results of the six indicators of sex hormones in the remote analysis module by the doctor, and sends the analysis results to the mobile device terminal .
终端交互模块和移动设备终端用于在医生需要和检测者进行面对面沟通时和远程分析模块建立视频通话连接。The terminal interaction module and the mobile device terminal are used to establish a video call connection with the remote analysis module when the doctor needs to communicate face-to-face with the tester.
本发明的有益效果为：The beneficial effects of the present invention are:
本发明建立了远程的性激素六项的检测设备，且结合远程设备的所需的特点，使用酶联免疫法对性激素6项进行检测，降低设备的设置成本。在进行性激素检测时使用电化学血糖传感器检测血糖含量，同时使用该检测的血糖含量对性激素6项的检测结果进行定量的标定，避免了因为终端的使用环境造成酶联免疫法检测的精度降低；The present invention establishes remote testing equipment for six items of sex hormones, and combined with the required characteristics of the remote equipment, uses an enzyme-linked immunosorbent method to detect six items of sex hormones, reducing the cost of equipment setup. During the detection of sex hormones, the electrochemical blood sugar sensor is used to detect the blood sugar content, and at the same time, the detected blood sugar content is used to quantitatively calibrate the test results of the six sex hormones, which avoids the decrease in the accuracy of the enzyme-linked immunoassay due to the use environment of the terminal;
本发明还设置了专门的远程沟通功能，针对各种需要都有相应的应对措施，当用户检测结果正常时，可以直接将其检测结果发送至用户手机上；当用户检测结果稍有不正常但无需面对面交流时可以直接将注意事项发送至用户手机；这样可以大大节省医疗资源，且方便用户使用。当用户的检测结果异常，需要进一步交流时，医生可以通过终端交互模块或者用户的移动终端和用户进行沟通交流，进一步确定病情，多样的沟通方式可以很好的保证用户的隐私，且还可以方便没有移动终端的人群使用。The present invention also sets up a special remote communication function, which has corresponding countermeasures for various needs. When the user's detection result is normal, the detection result can be directly sent to the user's mobile phone; When there is no need for face-to-face communication, the precautions can be directly sent to the user's mobile phone; this can greatly save medical resources and is convenient for users to use. When the user's test results are abnormal and further communication is required, the doctor can communicate with the user through the terminal interaction module or the user's mobile terminal to further determine the condition. Various communication methods can ensure the user's privacy well, and can also facilitate It is used by people without mobile terminals.
附图说明Description of drawings
被包括来提供对所公开主题的进一步认识的附图，将被并入此说明书并构成该说明书的一部分。附图也阐明了所公开主题的实现，以及连同详细描述一起用于解释所公开主题的实现原则。没有尝试对所公开主题的基本理解及其多种实践方式展示超过需要的结构细节。The accompanying drawings, which are included to provide a further understanding of the disclosed subject matter, are incorporated in and constitute a part of this specification. The drawings also illustrate implementations of the disclosed subject matter and, together with the detailed description, serve to explain implementation principles of the disclosed subject matter. No attempt has been made to reveal more structural detail than is necessary for a fundamental understanding of the disclosed subject matter and its various ways of practicing it.
图1为本发明整体结构连接图；Fig. 1 is the connection diagram of overall structure of the present invention;
图2为本发明终端检测仪内部连接示意图；Fig. 2 is a schematic diagram of the internal connection of the terminal detector of the present invention;
图3为本发明酶联免疫性激素检测仪示意图。Fig. 3 is a schematic diagram of the ELISA hormone detector of the present invention.
具体实施方式Detailed ways
本发明的优点、特征以及达成所述目的的方法通过附图及后续的详细说明将会明确。The advantages, characteristics, and means for achieving the object of the present invention will be clarified by the accompanying drawings and detailed descriptions that follow.
实施例1：Example 1:
一种远程内分泌紊乱检测设备，包括远程主机、远程分析模块、终端检测仪、终端交互模块、移动设备终端；远程主机连接远程分析模块、终端检测仪、终端交互模块、移动设备终端，终端检测仪连接终端交互模块、移动设备终端；远程分析模块连接终端交互模块、移动设备终端；A remote endocrine disorder detection device, including a remote host, a remote analysis module, a terminal detector, a terminal interaction module, and a mobile device terminal; the remote host is connected to the remote analysis module, the terminal detector, the terminal interaction module, the mobile device terminal, and the terminal detector Connect the terminal interaction module and the mobile device terminal; the remote analysis module connects the terminal interaction module and the mobile device terminal;
终端检测仪用于对性激素水平进行检测，其设置有主控制器、录音设备、显示设备、电化学血糖传感器、酶联免疫性激素检测仪1；主控制器连接录音设备、显示设备、电化学血糖传感器、酶联免疫性激素检测仪1；显示设备用于在检测时显示使用者需要回答的问题，录音设备用于记录使用者的语音；The terminal detector is used to detect the level of sex hormones. It is equipped with a main controller, a recording device, a display device, an electrochemical blood sugar sensor, and an enzyme-linked immune hormone detector 1; the main controller is connected to the recording device, the display device, and the electrochemical blood sugar sensor. Sensor, ELISA hormone detector 1; the display device is used to display the questions that the user needs to answer during the detection, and the recording device is used to record the user's voice;
电化学血糖传感器用于检测血糖含量；酶联免疫性激素检测仪1包括检测器和激素检测试纸2；检测试纸2包括7条检测线和1条质控线；检测器包括试纸插槽和8个与试纸上的检测线和质控线对应的检测头；The electrochemical blood sugar sensor is used to detect blood sugar content; the ELISA hormone detector 1 includes a detector and a hormone detection test paper 2; the detection test paper 2 includes 7 detection lines and 1 quality control line; the detector includes a test paper slot and 8 The detection head corresponding to the detection line and quality control line on the test strip;
终端检测仪将检测的性激素6项水平以及其记录的语音发送至远程主机；终端交互模块和移动设备终端用于供用户与医生进行语音视频交流；远程分析模块用于显示性激素6项水平以及播放记录的语音，并供医生与用于进行语音视频交流。The terminal detector sends the detected levels of the six sex hormones and the recorded voice to the remote host; the terminal interaction module and the mobile device terminal are used for voice and video communication between the user and the doctor; the remote analysis module is used to display the levels of the six sex hormones and play The recorded voice can be used by doctors for voice and video communication.
终端检测仪、终端交互模块一体设置，终端交互模块设置有终端显示屏、耳机、麦克风、高清摄像头；移动设备终端为手机或者平板电脑。The terminal detector and the terminal interaction module are integrated, and the terminal interaction module is equipped with a terminal display screen, earphones, microphones, and high-definition cameras; the mobile device terminal is a mobile phone or a tablet computer.
电化学血糖传感器内设置有电化学血糖监测模块和制样模块，用于对血液样品的血样进行电化学监测，并将血液样品制作成血清加载至激素检测试纸2上；The electrochemical blood sugar sensor is equipped with an electrochemical blood sugar monitoring module and a sample preparation module, which are used to electrochemically monitor the blood sample of the blood sample, and make the blood sample into serum and load it on the hormone detection test paper 2;
激素检测试纸2上设置有用于检测卵泡生成激素FSH、黄体生成激素LH、雌二醇E2、孕酮P、睾酮T、催乳激素PRL共六项的酶联免疫检测线以及一条用于检测检测试纸2是否正常的质控线和一条基于酶联免疫检测血糖含量的检测线；Hormone detection test paper 2 is provided with six enzyme-linked immunoassay lines for detection of follicle generating hormone FSH, luteinizing hormone LH, estradiol E2, progesterone P, testosterone T, and prolactin PRL, and a test paper for detection 2 Whether the quality control line is normal and a test line based on enzyme-linked immunosorbent assay for blood sugar content;
当激素检测试纸2插入试纸插槽时，每一条检测线和质控线的上方均设置有一个发光头3和一个受光头4；发光头3提供固定强度的照明，受光头4用于检测检测线或者质控线对应波长的的光亮度；When the hormone detection test paper 2 is inserted into the test paper slot, a light-emitting head 3 and a light-receiving head 4 are arranged above each test line and quality control line; the light-emitting head 3 provides illumination with a fixed intensity, and the light-receiving head 4 is used for detection and detection The brightness of the corresponding wavelength of the line or quality control line;
终端检测仪将收集到的电化学血糖传感器检测的血糖浓度和8个受光头检测的光亮度发送给远程主机。The terminal detector sends the collected blood glucose concentration detected by the electrochemical blood glucose sensor and the light brightness detected by the 8 light heads to the remote host.
远程主机内存储有性激素6项和血糖对应的酶联免疫的工作曲线，远程主机根据电化学血糖传感器检测的血糖浓度对血糖对应的受光头检测到的光亮度进行标定，然后根据标定的血糖浓度对性激素6项的指标进行定量计算，从而消除因环境和设备误差造成的酶联免疫检测的误差。The remote host stores the 6 items of sex hormones and the ELISA working curve corresponding to the blood glucose. The remote host calibrates the brightness of the light detected by the light head corresponding to the blood glucose according to the blood glucose concentration detected by the electrochemical blood glucose sensor, and then according to the calibrated blood glucose concentration Quantitative calculation of 6 indicators of sex hormones is performed to eliminate errors in enzyme-linked immunoassays caused by environmental and equipment errors.
远程主机将性激素6项的指标以及终端检测仪检测时记录的语音发送至远程分析模块，远程分析模块收集医生在远程分析模块针对性激素6项指标的分析结果，并将分析结果发送给移动设备终端。The remote host sends the six indicators of sex hormones and the voice recorded by the terminal detector to the remote analysis module, and the remote analysis module collects the analysis results of the six indicators of sex hormones in the remote analysis module by the doctor, and sends the analysis results to the mobile device terminal .
终端交互模块和移动设备终端用于在医生需要和检测者进行面对面沟通时和远程分析模块建立视频通话连接。The terminal interaction module and the mobile device terminal are used to establish a video call connection with the remote analysis module when the doctor needs to communicate face-to-face with the tester.
实施例2：本实施例针对本发明装置的使用方式进行说明。Embodiment 2: This embodiment describes how to use the device of the present invention.
使用时患者首先到设置有终端检测仪的部门进行检测，终端检测仪可以设置在药店、小型诊所、甚至社区活动中心；然后使用者让护士或者其他工作人员抽血，抽出的血用于进行血糖的电化学检测；检测完成之后将血样制作成血清，并加载到试纸上；When using it, the patient first goes to a department equipped with a terminal detector for testing. The terminal detector can be installed in a pharmacy, a small clinic, or even a community activity center; then the user asks a nurse or other staff to draw blood, and the drawn blood is used for blood sugar Electrochemical detection; After the detection is completed, the blood sample is made into serum and loaded onto the test paper;
然后使用酶联免疫性激素检测仪对试纸进行分析，分析结果发送至远程主机；在进行检测的同时，终端检测仪的显示装置上显示使用者需要回答的问题，使用者可以通过录音模块录音。录音会一并发送至远程主机。Then use the enzyme-linked immunosorbent hormone detector to analyze the test paper, and the analysis results are sent to the remote host; while the detection is being performed, the display device of the terminal detector displays the questions that the user needs to answer, and the user can record through the recording module. The recording will be sent to the remote host together.
在进行性激素检测时使用电化学血糖传感器检测血糖含量，目的是使用该检测的血糖含量对性激素6项的检测结果进行定量的标定，避免了因为终端的使用环境造成酶联免疫法检测的精度降低；In the detection of sex hormones, the electrochemical blood sugar sensor is used to detect the blood sugar content. The purpose is to use the detected blood sugar content to quantitatively calibrate the test results of the six sex hormones, and to avoid the decrease in the accuracy of the enzyme-linked immunoassay due to the use environment of the terminal. ;
医生通过远程分析模块分析患者的病情，当用户检测结果正常时，可以直接将其检测结果发送至用户手机上；当用户检测结果稍有不正常但无需面对面交流时可以直接将注意事项发送至用户手机；这样可以大大节省医疗资源，且方便用户使用。当用户的检测结果异常，需要进一步交流时，医生可以通过终端交互模块或者用户的移动终端和用户进行沟通交流，进一步确定病情，多样的沟通方式可以很好的保证用户的隐私，且还可以方便没有移动终端的人群使用。The doctor analyzes the patient's condition through the remote analysis module. When the user's test result is normal, the test result can be directly sent to the user's mobile phone; when the user's test result is slightly abnormal but there is no need for face-to-face communication, the precautions can be directly sent to the user. Mobile phones; this can greatly save medical resources and is convenient for users to use. When the user's test results are abnormal and further communication is required, the doctor can communicate with the user through the terminal interaction module or the user's mobile terminal to further determine the condition. Various communication methods can ensure the user's privacy well, and can also facilitate It is used by people without mobile terminals.
以上所述，仅为本发明的优选实施方式，但本发明的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本发明揭露的技术范围内，可轻易想到变化或替换，都应涵盖在本发明的保护范围之内。因此，本发明的保护范围应以所述权利要求的保护范围为准。The above is only a preferred embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Anyone skilled in the art can easily think of changes or substitutions within the technical scope disclosed in the present invention. Should be covered within the protection scope of the present invention. Therefore, the protection scope of the present invention should be determined by the protection scope of the claims.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010007492.2A CN111166289B (en) | 2020-01-04 | 2020-01-04 | A remote endocrine disorder detection device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010007492.2A CN111166289B (en) | 2020-01-04 | 2020-01-04 | A remote endocrine disorder detection device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111166289A CN111166289A (en) | 2020-05-19 |
| CN111166289B true CN111166289B (en) | 2023-02-24 |
Family
ID=70618682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010007492.2A Expired - Fee Related CN111166289B (en) | 2020-01-04 | 2020-01-04 | A remote endocrine disorder detection device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111166289B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112133436B (en) * | 2020-10-13 | 2021-06-29 | 广州万孚健康科技有限公司 | Health warning method and system based on big data analysis and readable storage medium |
| CN114778629B (en) * | 2022-04-28 | 2023-10-20 | 孟栋栋 | Clinical blood drawing detection device for medical endocrinology department |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8394246B2 (en) * | 2009-02-23 | 2013-03-12 | Roche Diagnostics Operations, Inc. | System and method for the electrochemical measurement of an analyte employing a remote sensor |
| CN102822834B (en) * | 2010-04-07 | 2020-09-25 | 诺华探索公司 | Computer-based system for predicting treatment outcome |
| CN101839908B (en) * | 2010-05-28 | 2014-08-20 | 李金波 | Biological fluid sample quantitative detection device and detection method |
| CN102183570A (en) * | 2011-02-14 | 2011-09-14 | 北京软测科技有限公司 | Implementation method and detector for improving blood detection accuracy |
| CN104718557A (en) * | 2012-08-01 | 2015-06-17 | 优菲米特有限责任公司 | User Interface for Analyte Monitoring Systems |
| CN105266822B (en) * | 2014-05-27 | 2018-08-24 | 普林斯顿医疗科技（珠海）有限公司 | Lossless blood-sugar detecting instrument based on Ocular Vessels blood Raman scattering and detection method |
| CN104266996A (en) * | 2014-10-07 | 2015-01-07 | 复旦大学 | Multifunctional non-invasive and portable medical detection device and method based on near-infrared spectrum analysis |
| CN108354614A (en) * | 2017-01-26 | 2018-08-03 | 李韦辰 | Blood glucose detection method, blood glucose detection correction method, and blood glucose detection device |
| CN109124648A (en) * | 2018-07-17 | 2019-01-04 | 桂林电子科技大学 | Insulin action factor calculation method based on energetic supersession conservation method noninvasive dynamics monitoring model |
-
2020
- 2020-01-04 CN CN202010007492.2A patent/CN111166289B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN111166289A (en) | 2020-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10627362B2 (en) | Blood glucose measuring device and method, and electronic device including blood glucose measuring module | |
| CN111166289B (en) | A remote endocrine disorder detection device | |
| WO2014157945A1 (en) | Bio-information measuring watch and method for measuring bio-information | |
| CN102670307A (en) | Self-service health monitoring system of community | |
| WO1995016970A1 (en) | Medical measuring apparatus | |
| WO2018111039A1 (en) | Method for charging electronic device, electronic device, and storage medium | |
| JP2014219392A (en) | Analyte meter digital sample detection | |
| US20170332993A1 (en) | Wheezing-related information display apparatus | |
| ZHU et al. | Increased mean glucose levels in patients with polycystic ovary syndrome and hyperandrogenemia as determined by continuous glucose monitoring | |
| Sugawara et al. | Telemedicine in nephrology: future perspective and solutions | |
| CN112185499A (en) | Management method and device of blood pressure data, terminal equipment and medium | |
| WO2021080292A1 (en) | Electronic device for integrating and presenting physiological data between multiple devices and method thereof | |
| TW201731460A (en) | Hemoglobin and hematocrit analyzer and analyzing method thereof | |
| AU2019208949A1 (en) | Apparatus and method for determining calibration timing for blood pressure measurement in electronic device | |
| CN107898444A (en) | A kind of long-range monitoring nursing system for iii trimester pregnancies | |
| CN103705248A (en) | Glucometer system with automatic diagnosis function | |
| JP2013501940A (en) | Graphical interface for analyte meter | |
| CN208422432U (en) | A kind of remote diagnosis system | |
| CN207052302U (en) | It is related to the Data Collection and quality control system of the sufferer therapeutic effect after discharge | |
| CN212008623U (en) | Intelligent blood glucose meter | |
| CN202330439U (en) | Blood-glucose detection device and blood-glucose detection system | |
| CN206303898U (en) | A kind of home blood parameter monitoring system | |
| TWI901087B (en) | Smart measuring system and method for thereof | |
| CN204931657U (en) | A kind of health intelligent monitoring terminal based on nearly long range radio transmissions | |
| CN205306961U (en) | A fixed check out test set for division of endocrinology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20230224 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |